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ABSTRACT 
 
Refractory and mortality associated with status epilepticus (SE) were correlated 
with the degree of inflammation-induced neuronal cell death. This study was 
aimed to investigate the correlation of oxidative stress (Malondialdehyde, MDA) 
and inflammation (C-reactive protein, CRP) process with neurodevelopmental 
outcome in children after the episode of convulsive type SE. This study was de-
signed as cross sectional which included 26 convulsive type SE subjects and 15 
control subjects. MDA level was measured by thiobarbituric acid (TBA) method, 
while CRP level was measured by ELISA method. Neurodevelopmental outcome 
was measured by Bayley-III Scale of Infant and Toddler Development 3 month 
after the convulsive type SE episode. Results showed that both MDA (independent 
t-test, p < 0.05) and CRP (Mann-Whitney test, p < 0.05) level was significantly 
higher in convulsive type SE group as compared to control group. Further analysis 
also showed that MDA (Spearman correlation test, p = 0.000, r = 0.756) and CRP 
(Spearman correlation test, p = 0.000, r = 0.835) level was positively correlated 
with convulsive type SE. In convulsive type SE group, MDA level was negatively 
correlated with neurodevelopmental outcome but CRP was not. We concluded that 
MDA level was negatively correlated with neurodevelopmental outcome in chil-
dren with convulsive type SE, but CRP was not. 
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Introduction 
Status epilepticus (SE) is defined as prolonged 
seizure which occurred for 20-30 minutes or re-
peated seizure in which patients is unconscious be-
tween two episodes of seizures [1, 2]. Convulsive 
SE is a generalized SE with tonic-clonic, tonic, 
clonic, and myoclonic movement. The incidence 
of SE in children aged 1-19 years old was approx-
imately 10 – 58 cases/100.000/ year [1, 2]. In chil-
dren below 1 year old, the incidence of SE was 
higher (135.2 – 156 cases/100.000/ year [1, 2]. 
As reported before, repeated seizure could 
lead to neurodevelopmental impairment such as 
cognitive dysfunction and behavior and emotional 
disturbances [3,4]. Similarly, children with refrac-
tory SE could lead to the visual and motoric deficit 
after the onset of SE [5]. A retrospective study 
showed that several neurological abnormalities 
were found in children after the episode of SE such 
as impairment of speech, coordination and behav-
ior, hemiplegia, and epilepsy [6]. Many factors 
were considered to triggered neurodevelopmental 
outcome in SE such as aged less than 12 years old 
and focal onset seizure [7]. 
In a seizure, the inflammatory condition could 
lead to the formation of reactive oxygen species 
(ROS) and lipid peroxidation which in turn lead to 
neuronal apoptosis and necrosis [8]. Malondialde- 
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hyde (MDA) as the end product of lipid peroxida-
tion could cause DNA damage and sequentially 
activate neuronal apoptotic pathway [9, 10]. MDA 
binds and cross-reacts with various biological 
macromolecules such as protein and nucleid acid 
and altered its functionality then impaired neuro-
developmental process [11].  
C-reactive protein (CRP) is acute phase pro-
tein that secreted by hepatic tissue and widely used 
as inflammation or infection marker [12]. In SE, 
CRP could be used as a predictor for refractory 
and prognostic marker. CRP was elevated in pilo-
carpine-induced SE rat model [13]. Furthermore, 
CRP also elevated in patient with refractory SE 
and its level was correlated with mortality [14]. 
This study was aimed to investigate the corre-
lation of MDA and CRP level with neurodevelop-
mental outcome after the episode of convulsive 
type SE in children. 
 
Material and Methods 
Study design 
This study was designed as a cross sectional to 
evaluate the neurodevelopmental outcome of chil-
dren aged 1 – 42 months old after convulsive type 
SE episode (3 months follow up period). Further-
more, this study was aimed to correlate the MDA 
and CRP level in the first day of convulsive type 
seizure episode with neurodevelopmental out-
come. This study was conducted at Pediatric 
Ward, Emergency Room, and pediatric outpatient 
care of Saiful Anwar Hospital, Malang, Indonesia; 
Physiology Laboratory of Medical Faculty of 
Brawijaya University. All of the procedure had 
been approved by Ethical Committee of Research 
Saiful Anwar Hospital issued by Ethical Clearance 
number 400/18/K.3/302/2016. 
 
Subject and population 
Inclusion criteria for the sample are as follows: 
aged 1 – 42 months with convulsive type SE, nor-
mal developmental status before convulsive type 
SE episode, and allowed by his/her parents to join 
this study. Inclusion criteria for control are as fol-
lows: a pediatric patient who attended pediatric 
outpatient care without seizure, normal develop-
mental status and allowed by his/her parents to 
join this study (represented by signed informed 
consent form). Exclusion for sample and control 
are as follows: children with major congenital dis-
eases, history of trauma or intracranial procedure 
which associated with impaired developmental 
status, and severe sepsis. Drop out criteria for all 
subjects are as follows: lysis of blood sampling, 
died or underwent the intracranial procedure dur-
ing the study, intracranial structural abnormality 
after the episode of convulsive type SE, and didn’t 
come at follow up period. 
 
Sample size calculation 
The formula to calculate the sample size for 
this study was: 
 
N =
𝑍2𝑆𝐷2
𝑑2
 
Note: 
Z = standard normal variate (at 5% type 1 error (p < 
0.05) it is 1.96) 
SD = standard deviation of variable.  
d = absolute error or precision 
 
Based on pilot study, SD of CRP level was 
0.25 and the d value was 15%, so the sample size 
derived from the formula was 10.67. Hence, 15 
subjects were recruited in this study. 
 
Blood sampling 
Subjects who met inclusion criteria was under-
gone to take his/her blood at the first day of con-
vulsive type SE episode. Venous blood sample 
was transferred to the laboratory using tube until it 
coagulated (2 hours at room temperature, over-
night at 4°C). After this, the sample was centri-
fuged for 20 minutes at 1000 rpm. Plasma which 
separated after centrifugation process was imme-
diately examined for MDA and CRP measurement 
or stored at -40°C or -80°C. 
 
Measurements of MDA 
Thiobarbituric acid (TBA) was made by mix-
ing of 0.67 g TBA in 100 mL aquabidest, then 
added by 0.5 gsodium hydroxide and 100 mL gla-
cial acetic acid. Serial standard solution and stock 
solution (MDA 125 uL in 100 mL aquabidest) 
were prepared. As many 100 uL plasma sample 
and standard were transferred into each tube. Each 
tube was added with 0.9 mL aquabidest and 0.5 
mL reagent TBA. A mixture of sample/ standard 
together with TBA reagent was heated using water 
bath at 95°C for 1 hour. After this process, each 
tube was centrifuged at 7,000 rpm for 10 minutes. 
Supernatant was taken from each tube and analy- 
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zed for its absorbance value using spectrophotom-
eter (wavelength 532 nm).  
 
Measurement of CRP 
CRP level was examined by ELISA method. 
ELISA procedure was performed as instructed by 
manufacturer (Human C-Reactive Protein Quanti-
kine ELISA Kit, RnD systems, catalogue number 
DCRP00). Briefly, plasma sample which had been 
obtained from the previous procedure was thawed 
at room temperature. All ELISA reagents include 
standard solution, assay diluent A and B, detection 
reagent A and B, washing solution, and TMB sub-
strate were prepared. 100 uL assay diluent RD1F 
was added into each well. 50 uL standard, control, 
or sample were added to each well and closed with 
an adhesive strip, then incubated for 2 hours at 
37˚C. After incubation process, each well was as-
pirated and added to 400 uL washing solution. 
This washing process was repeated for 3 times. 
After washing process, 200 uL CRP conjugate was 
added to each well, closed with an adhesive strip, 
and then incubated for 2 hours at room tempera-
ture. Washing process was repeated as described 
before. 200 uL substrate solution was added to 
each well then incubated for 30 minutes at room 
temperature in the dark room. 50 uL stop solution 
was added to each well. Microplate then analyzed 
for its absorbance value using ELISA reader at 
wavelength 450 nm after 30 minutes. CRP level 
was determined by plotting each sample’s absorb-
ance value into a standard curve. 
 
Assessment of neurodevelopmental outcome 
Basically, the neurodevelopmental outcome 
was measured by Bayley-III Scale of Infant and 
Toddler Development. This scale was divided into 
3 main scores: motoric, language, and cognitive 
score [16, 17]. 
 
Statistical analysis 
First, data of MDA, CRP level and neurode-
velopmental were analyzed for their distribution 
and homogeneity. In order to analyze the differ-
ences of MDA, CRP level and neurodevelopmen-
tal outcome between groups, independent t-test 
(Mann-Whitney test as an alternative) was per-
formed. Correlation of status epilepticus and 
MDA and CRP level, status epilepticus and neuro 
developmental outcome; CRP and MDA level and 
neurodevelopmental outcome were analyzed us- 
ing Pearson correlation test (Spearman correlation 
test as an alternative). All the statistical analyses 
were performed using software SPSS version 
23.0. 
 
Results and Discussion 
Baseline characteristics 
This study was included children with convul-
sive type status epilepticus which hospitalized in 
Saiful Anwar General Hospital Malang. As many 
as 41 subjects were included in this study which 
divided into 26 subjects as convulsive type status 
epilepticus group and 15 subjects in the control 
group. Baseline characteristics of convulsive type 
status epilepticus group were shown in Table 1. 
This study observed neurodevelopmental out-
come (cognitive, language, and motoric based on 
Bayley III) in children diagnosed with convulsive 
type status epilepticus 3 months after convulsive 
type seizure episode. Of 40 subjects with convul-
sive type status epilepticus, only 26 subjects were 
 
Table 1. Characteristics of subjects 
Characteristics Number (n) 
Sex  
- Male 15 
- Female 11 
Age (months)  
- 0 – 6  5 
- 7 – 12 6 
- 13 – 24 10 
- > 24 5 
Nutritional Status  
- Over-Nutrition 1 
- Good 9 
- Undernutrition 13 
- Malnourished 3 
Mother's Educational Background  
- Senior High School and above level 17 
- Junior High School and below level 9 
Hemoglobin Level (g/dL)  
- < 11.0 13 
- > 11.0 13 
Leukocyte Count (cells/mm3)  
- < 10,000 10 
- 10,000 – 15,000 5 
- > 15,000 11 
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Figure 1. Mean of MDA level (pg/mL) in control and 
convulsive type SE group  
 
Figure 2.  Correlation graph of MDA level and cogni-
tive composite in convulsive type SE group 
 
analyzed. As many as 14 subjects were dropped 
out caused by died (4 subjects), underwent an in-
tracranial procedure or severe disease (5 subjects), 
and did not come at follow-up period (5 subjects). 
Characteristic of subjects in convulsive type status 
epilepticus group showed that male was more than 
the female subject (15 of 26 subjects). The most 
age interval was 13 – 24 months old in convulsive 
type SE group. Interestingly, nutritional status of 
subjects in convulsive type SE group was mainly 
undernutrition and malnourished, indicating that 
poor nutrition status increases the vulnerability to 
severe infection. Educational background of the 
mother seems did not contribute to the develop-
ment of status epilepticus. However, this aspect 
needs further investigation.  
Hemoglobin level might do not significantly  
increase the risk of convulsive type status epilep-
ticus. However, it needs further research about the 
role of hemoglobin level in the progression of dis-
ease. Leukocyte count in convulsive type status 
epilepticus group showed that almost patient had 
leukocyte count above 10,000 cells/mm3 and 5 
among those group had leukocyte count above  
15,000 cells/mm3, suggesting that severe inflam-
mation such as complex febrile seizure or menin-
goencephalitis could be associated with status ep-
ilepticus. Normal leukocyte condition which could 
contribute to triggering status epilepticus such as 
uncontrolled epilepsy (poor patient’s obedience to 
take drug) and electrolyte imbalance (severe vom-
iting and diarrhea). 
 
MDA level 
Result showed that MDA level in convulsive 
type SE group (41.35 ± 3.93 pg/mL) was signifi-
cantly higher as compared to control group (24.28 
± 2.69 pg/mL) (independent t-test, p < 0.05). The 
mean of MDA level in both convulsive type SE 
and control group was shown in Figure 1. Further-
more, Spearman correlation test showed that con-
vulsive type status epilepticus was positively co- 
related with MDA level (p = 0.000, r = 0.756). Ma- 
londialdehyde is a marker for lipid peroxidation 
and known as the most mutagenic lipid peroxida-
tion end product. Oxidative stress which leads to 
reactive oxygen species (ROS) formation was as-
sociated with the pathological finding in acute sei-
zure, status epilepticus, and epilepsy. Evidence 
showed that ROS was elevated in in vivo model of 
epilepsy marked by reduced glutathione level [17, 
18]. Reactive oxygen species could impair cell in-
tegrity mediated by MDA formation [19].  
An experimental study using rat SE model (pi-
locarpine-induced) demonstrated that MDA level 
was elevated in prolonged seizure group as com-
pared to repeated group [20]. Further analysis 
showed that neuronal cell death and single strand 
DNA was elevated in prolonged seizure group as 
compared to repeated seizure [20].  
Similarly, other experimental study using pi-
locarpine-induced rat SE model also showed that 
hippocampal oxidative stress marked by lipid pe-
roxidation and nitrite content was elevated in SE 
group as compared to control group [21]. Using 
the same model, Junior and colleagues also 
demonstrated that lipid peroxidation in striatum 
area (47%) and frontal cortex (59%) were elevated 
[22]. Previous studies suggested that oxidative 
stress which triggered lipid peroxidation might 
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Figure 3.  Correlation graph of MDA level and lan-
guage composite in convulsive type SE 
group 
 
Figure 4. Correlation graph of MDA level and motoric 
composite in convulsive type SE group 
 
Figure 5. Mean of CRP level (pg/mL) in control and 
convulsive type SE group 
have crucial role in SE. 
 
Correlation of MDA level and neurodevelopmen-
tal outcome 
Correlation study of MDA level and neurode-
velopmental outcome demonstrated that MDA 
level was negatively correlated with cognitive 
composite (Spearman correlation test, p = 0.000, r 
= -0.800). Similarly, MDA level was negatively 
correlated with language composite (Pearson cor-
relation test, p = 0.000, r = -0.648). Further analy-
sis also showed that MDA level was negatively 
correlated with motoric composite (Spearman cor-
relation test, p = 0.000, r = -0.732).  Overall, cor-
relation study confirmed that MDA level was neg-
atively correlated with neurodevelopmental out-
come in convulsive type status epilepticus chil-
dren based on cognitive, language, and motoric as-
pect.  Correlation graph of MDA level and cogni-
tive composite, language composite, and motoric 
composite was shown in Figure 2, Figure 3, and 
Figure 4, respectively. These results suggested 
that MDA has an important role in the occurrence 
of neuron hyper-excitability and inflammation-in-
duced neuronal injury which lead to refractory sei-
zure and post-seizure neurodevelopmental dys-
function.  
Several studies had been conducted to investi-
gate neurodevelopmental outcome in SE. Saz and 
colleagues reported that children with refractory 
SE might experience visual and motoric deficit af-
ter the onset of seizure [23]. Another observational 
study also reported that 18% children with SE ex-
perience neurological sequelae at the day they dis-
charged from hospital and further analysis showed 
that hypoglycemia, aged less than 12 years old, 
and focal onset seizure increase those Sequleae’s 
occurrence [7]. The retrospective study also 
demonstrated that 9 children with SE experience 
impairment of speech, coordination and behavior, 
hemiplegia, and epilepsy development after the 
onset of the seizure [6]. Repeated seizure post en-
cephalitis also insignificantly increases the risk of 
epilepsy (OR 2.4) [24].  
MDA could bind and cross-react with various 
macromolecules such as protein and nucleic acid 
which played an important role in neuronal devel-
opment [11]. In vivo study also showed that MDA 
could cause an imbalance of glutamate and GABA 
(gamma amino butyric acid) activity and induce 
neuronal apoptotic pathway [9].  
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Oxidative stress was not only involved MDA, 
but also other ROS which formed at hyper-
metabolic state (seizure) and mediated by activa-
tion of NADPH oxidase and xanthine oxidase 
[25]. Oxidative stress considered as an important 
factor for the development of brain pathological 
condition in seizure (acute seizure, status epilepti-
cus, and epilepsy) [26]. Oxidative stress had a con-
tribution to the development of neuronal cell death 
[18], and several studies showed that MDA in-
creases the risk of chronic epilepsy development 
[19,27]. The source of cellular oxygen free radical 
were mitochondria [28], NADPH activation [29], 
xanthine oxidase action [30] and those free radi-
cals involved in the development of pathological 
condition such as epilepsy and stroke.  
 
CRP level 
Result showed that CRP level in convulsive 
type SE group (1.32 ± 0.94 pg/mL) was signifi-
cantly higher as compared to control group (0.3 ± 
0.07 pg/mL) (Mann-Whitney test, p < 0.05). The 
mean of CRP level in both convulsive type SE and 
control group was shown in Figure 5. Furthermo- 
re, Spearman correlation test showed that convul-
sive type status epilepticus was positively corre-
lated with CRP level (p = 0.000, r = 0.835). 
 
Correlation of CRP level and neurodevelopmen-
tal outcome 
Correlation study of CRP level and neurode-
velopmental outcome demonstrated that CRP 
level was insignificantly correlated with cognitive 
composite (Spearman correlation test, p = 0.640, r 
= - 0.096). Similarly, CRP level was insignifi-
cantly correlated with language composite (Spear-
man correlation test, p = 0.549, r = - 0.123). Fur-
ther analysis also showed that CRP level was in-
significantly correlated with motoric composite 
(Spearman correlation test, p = 0.944, r = 0.015).  
Overall, correlation study confirmed that CRP 
level was insignificantly correlated with neurode-
velopmental outcome in convulsive type status ep-
ilepticus children based on cognitive, language 
and motoric aspect. 
C-reactive protein is acute phase protein 
which secreted by hepatic tissue as a response to 
inflammation include meningoencephalitis. CRP 
level was also increased in epilepsy and this fact 
suggested that systemic inflammation was associ-
ated with general seizure in epilepsy [31, 32]. In 
SE, CRP was used a predictor for refractory SE 
and predictor for prognostic SE patient. Observa-
tional study included 160 patients from ICU 
demonstrated that CRP and procalcitonin could be 
used as a predictor for infection in SE patient (sen-
sitivity 83% and 94%, respectively; negative pre-
dictive value increase for 3 days for 97%) [14]. 
CRP also used as an outcome predictor in SE pa-
tient. Cohort study revealed that elevated CRP 
level was associated with refractory SE and mor-
tality [32].  
Consistent with the previous study, an experi-
mental study using pilocarpine-induced model 
also showed that CRP was increased in SE group 
as compared to control [13]. Retrospective cohort 
study further showed that the outcome of children 
with SE was associated with age < 24 months, sei-
zure duration > 90 minutes, abnormal blood glu-
cose level (< 61 or > 250 mg/dL), AST level > 56 
UI/L, and CRP level > 2.00 mg/dL (univariate 
analysis) [32]. Multivariate analysis further con-
firmed that young age, abnormal blood glucose 
level, elevated AST and CRP level was signifi-
cantly correlated with poor prognosis [32]. How-
ever, our study did not show any correlation be-
tween CRP level and neurodevelopmental out-
come in convulsive type status epilepticus chil-
dren and this might be caused by timing and loca-
tion of blood sampling which did not represent the 
peak of inflammation and cerebral inflammation.  
 
Conclusion 
We concluded that MDA level was negatively 
correlated with neurodevelopmental outcome in 
children after the episode of convulsive type status 
epilepticus, but CRP was not. 
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